Avanos Medical (NYSE:AVNS – Get Free Report) will likely be releasing its earnings data before the market opens on Wednesday, February 26th. Analysts expect Avanos Medical to post earnings of $0.40 per share and revenue of $177.23 million for the quarter.
Avanos Medical Price Performance
Shares of Avanos Medical stock opened at $15.53 on Friday. The stock has a market cap of $713.48 million, a price-to-earnings ratio of 45.66 and a beta of 0.98. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.46 and a current ratio of 2.22. The stock has a 50 day moving average price of $16.27 and a 200-day moving average price of $19.92. Avanos Medical has a one year low of $14.98 and a one year high of $25.36.
Analysts Set New Price Targets
Separately, StockNews.com cut Avanos Medical from a “strong-buy” rating to a “buy” rating in a report on Sunday, November 3rd.
Avanos Medical Company Profile
Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.
Read More
- Five stocks we like better than Avanos Medical
- Quiet Period Expirations Explained
- Ray Dalio’s Bridgewater Loaded Up on These Stocks in Q4 2024
- Dividend Payout Ratio Calculator
- Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive
- How to Use the MarketBeat Excel Dividend Calculator
- Tesla: 2 Reasons to Buy, 1 Reason to Run
Receive News & Ratings for Avanos Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avanos Medical and related companies with MarketBeat.com's FREE daily email newsletter.
